Yield10 Bioscience Inc (YTEN) 뉴스

Yield10 Bioscience Announces Closing of $3.7 Million Public Offering

WOBURN, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the...

Yield10 Bioscience Announces Second Quarter 2023 Financial Results

-Harvesting underway for contracted winter and spring Camelina acres for the biofuels market-Reported positive...

Form 8-K - Current report

Form 424B4 - Prospectus [Rule 424(b)(4)]

Yield10 Bioscience to Announce Second Quarter 2023 Financial Results and Host a Conference Call on Monday, August 14, 2023

WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the...

Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering

WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the...

Form EFFECT - Notice of Effectiveness

Form 8-K - Current report

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market

-Findings demonstrate a key advancement in the development of proprietary Camelina varieties tolerant to...

Yield10 Bioscience Files Request for Regulatory Status Review under USDA-APHIS’s SECURE Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil

-Omega-3 (EPA) Camelina planted at acre-scale in US nearing maturity -Development program moving forward at a...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form DEL AM - Delaying amendment